Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Axogen (AXGN) Invested Capital (2016 - 2025)

Historic Invested Capital for Axogen (AXGN) over the last 16 years, with Q3 2025 value amounting to $169.0 million.

  • Axogen's Invested Capital rose 1519.51% to $169.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $169.0 million, marking a year-over-year increase of 1519.51%. This contributed to the annual value of $151.4 million for FY2024, which is 642.1% up from last year.
  • Latest data reveals that Axogen reported Invested Capital of $169.0 million as of Q3 2025, which was up 1519.51% from $160.2 million recorded in Q2 2025.
  • Axogen's Invested Capital's 5-year high stood at $169.0 million during Q3 2025, with a 5-year trough of $140.0 million in Q1 2024.
  • For the 5-year period, Axogen's Invested Capital averaged around $150.6 million, with its median value being $147.0 million (2022).
  • Its Invested Capital has fluctuated over the past 5 years, first surged by 2053.12% in 2021, then tumbled by 1082.08% in 2022.
  • Quarter analysis of 5 years shows Axogen's Invested Capital stood at $157.4 million in 2021, then fell by 6.77% to $146.7 million in 2022, then dropped by 3.03% to $142.3 million in 2023, then rose by 6.42% to $151.4 million in 2024, then rose by 11.6% to $169.0 million in 2025.
  • Its Invested Capital stands at $169.0 million for Q3 2025, versus $160.2 million for Q2 2025 and $153.1 million for Q1 2025.